Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age | Zendy

Rohan Arora | Zendy; Elliott Salamon | Zendy; Jeffrey M. Katz | Zendy; Margueritte Cox | Zendy; Jeffrey L. Saver | Zendy; Deepak L. Bhatt | Zendy; Gregg C. Fonarow | Zendy; Eric D. Peterson | Zendy; Eric E. Smith | Zendy; Lee H. Schwamm | Zendy; Ying Xian | Zendy; Richard Libman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age

Author(s) -

Rohan Arora,

Elliott Salamon,

Jeffrey M. Katz,

Margueritte Cox,

Jeffrey L. Saver,

Deepak L. Bhatt,

Gregg C. Fonarow,

Eric D. Peterson,

Eric E. Smith,

Lee H. Schwamm,

Ying Xian,

Richard Libman

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.012241

Subject(s) - medicine , contraindication , thrombolysis , stroke (engine) , tissue plasminogen activator , rehabilitation , mortality rate , fibrinolytic agent , pediatrics , surgery , physical therapy , myocardial infarction , mechanical engineering , alternative medicine , pathology , engineering

Intravenous tissue-type plasminogen activator (tPA) is a proven treatment for acute ischemic stroke, but there has been limited evaluation among patients aged ≥90 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research